Filters
| Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
|---|---|---|---|
Molecular Vision Laboratory United States | 1358 | 1028 |
|
Anterior Segment Dysgenesis Disorders Panel PreventionGenetics, part of Exact Sciences United States | 272 | 278 |
|
Invitae Microphthalmia, Anophthalmia, Coloboma (MAC) and Anterior Segment Dysgenesis Panel Labcorp Genetics (formerly Invitae) LabCorp United States | 130 | 81 |
|
Anterior segment dysgenesis: Full gene sequencing panel CEN4GEN Institute for Genomics and Molecular Diagnostics Canada | 8 | 8 |
|
Labcorp Genetics (formerly Invitae) LabCorp United States | 57 | 27 |
|
CGC Genetics Unilabs Portugal | 1 | 18 |
|
CGC Genetics Unilabs Portugal | 1 | 26 |
|
Microphthalmia, Anophthalmia and Coloboma Panel CGC Genetics Unilabs Portugal | 1 | 91 |
|
Laboratorio de Genetica Clinica SL Spain | 1 | 50 |
|
Clinical Biochemical Genetics Diagnostic Laboratory University Of Miami Miller School Of Medicine United States | 1 | 695 |
|
Early Onset Glaucoma Gene Sequencing Panel Clinical Biochemical Genetics Diagnostic Laboratory University Of Miami Miller School Of Medicine United States | 1 | 37 |
|
Microphthalmia, Anophthalmia, and Coloboma Panel NGS Panel Fulgent Genetics United States | 244 | 78 |
|
Fulgent Genetics United States | 5128 | 4672 |
|
Comprehensive Eye Disorders NGS Panel Fulgent Genetics United States | 1018 | 459 |
|
Centogene AG - the Rare Disease Company Germany | 417 | 413 |
|
PreventionGenetics, part of Exact Sciences United States | 157 | 171 |
|
PreventionGenetics, part of Exact Sciences United States | 38 | 24 |
|
Diseases of the posterior ocular segment (WES based NGS panel of 307 gene, including CNV analysis) CGC Genetics Unilabs Portugal | 1 | 307 |
|
CONGENITAL CATARACTS EXOME PANEL Laboratorio de Genetica Clinica SL Spain | 1 | 120 |
|
Genomic Unity® Custom Analysis Variantyx, Inc. United States | 1 | 4054 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.